Diarrea

Volver al artículo.

Referencias para el artículo

  1. Hyams JS, Etienne NL, Leichtner AM, Theuer RC. Carbohydrate malabsorption following fruit juice ingestion in young children. Pediatr 1988;82:64–8.
  2. Barness LA. Safety considerations with high ascorbic acid dosage. Ann NY Acad Sci 1975;258:523–8 [review].
  3. Babb RR. Coffee, sugars and chronic diarrhea. Postgrad Med 1984;75:82, 86–7.
  4. James JM, Burks AW. Food-associated gastrointestinal disease. Curr Opin Pediatr 1996;8:471–5 [review].
  5. Bowie MD, Hill ID, Mann MD. Response of severe infantile diarrhoea to soya-based feeds. S Afr Med J 1988;73:343–5.
  6. Pothoulakis C, Kelly CP, Joshi MA, et al. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993;104:1108–15.
  7. Surzwicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989;96:981–8.
  8. Bleichner G, Blehaut H, Mentec H, Moyse D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A muticenter, randomized, double-blind placebo-controlled trial. Intensive Care Med 1997;23:517–23.
  9. Kollaritsch H, Holst H, Grobara P, Widermann G. Prevention of traveler’s diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study. Fortschr Med 1993;111:152–6 [in German].
  10. Kirchelle A, Fruhwein N, Toburen D. Treatment of persistent diarrhea with S. boulardii in returning travelers. Results of a prospective study. Forstchr Med 1996;114:136–40 [in German].
  11. Plein K, Hotz J. Therapeutic effects of Saccharomyces on mild residual symptoms in a stable phase of Crohn’s disease with special respect to chronic diarrhea—a pilot study. Z Gastroenterol 1993;31:129–34.
  12. Lewis SJ, Potts LF, Barry RE. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J Infect 1998;36:171–4.
  13. Piarroux R, Millon L, Bardonnet K, et al. Are live saccharomyces yeasts harmful to patients? Lancet 1999;353:1851–2 [letter].
  14. Poupard JA, Hussain J, Norris RF. Biology of the bifidobacteria. Bact Rev 1973;37:136–65.
  15. Saavedra J. Probiotics and infectious diarrhea. Am J Gastroenterol 2000;95:S16–8 [review].
  16. Saavedra JM, Bauman NA, Oung I, et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994;344:1046–9.
  17. Colombel JF, Cortot A, Neut C, Romond C. Yogurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 1987;2:43 [letter].
  18. Pedone CA, Bernabeu AO, Postaire ER, et al. The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int J Clin Pract 1999;53:179–84.
  19. Saavedra J. Probiotics and infectious diarrhea. Am J Gastroenterol 2000;95:S16–8 [review].
  20. Montes RG, Perman JA. Lactose intolerance. Postgrad Med 1991;89:175–84 [review].
  21. Werbach MR. Nutritional influences on Illness, 2d ed. Tarzana, CA: Third Line Press, 1993, 256–61 [review].
  22. Bhan MK, Bhandari N. The role of zinc and vitamin A in persistent diarrhea among infants and young children. J Pediatr Gastroenterol Nutr 1998;26:446–53 [review].
  23. Schellenberg D, Bonington A, Champion C, et al. Treatment of Clostridium difficile diarrhea with brewer’s yeast. Lancet 1994;343:171–2 [letter].
  24. Izadnia F, Wong CT, Kocoshis SA. Brewer’s yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat. Dig Dis Sci 1998;43:2055–60.
  25. Sarker SA, Casswall TH, Mahalanabis D, et al. Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatr Infect Dis J 1998;17:1149–54.
  26. Mitra AK, Mahalanabis D, Ashraf H, et al. Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: a double- blind, controlled clinical trial. Acta Paediatr 1995;84:996–1001.
  27. Okhuysen PC, Chappell CL, Crabb J, et al. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin Infect Dis 1998;26:1324–9.
  28. Greenberg PD, Cello JP. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:348–54.
  29. Casswall TH, Sarker SA, Albert MJ, et al. Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum. Aliment Pharmacol Ther 1998;12:563–8.
  30. Huppertz HI, Rutkowski S, Busch DH, et al. Bovine colostrum ameliorates diarrhea in infection with diarrheagenic Escherichia coli, shiga toxin-producing E. Coli, and E. coli expressing intimin and hemolysin. J Pediatr Gastroenterol Nutr 1999;29:452–6.
  31. Warny M, Fatimi A, Bostwick EF, et al. Bovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine. Gut 1999;44:212–7.
  32. Brines RD, Brock JH. The effect of trypsin and chymotrypsin on the in vitro antimicrobial and iron-binding properties of lactoferrin in human milk and bovine colostrum. Unusual resistance of human apolactoferrin to proteolytic digestion. Biochim Biophys Acta 1983;759:229–35.
  33. Haffejee IE. Effect of oral folate on duration of acute infantile diarrhoea. Lancet 1988;2:334–5 [letter].
  34. Ashraf H, Rahman MM, Fuchs GJ, Mahalanabis D. Folic acid in the treatment of acute watery diarrhoea in children: a double-blind, randomized, controlled trial. Acta Pædiatr 1998;87:1113–5.
  35. Fawzi WW, Mbise R, Spiegelman D, et al. Vitamin A supplements and diarrheal and respiratory tract infections among children in Dar es Salaam, Tanzania. J Pediatr 2000;137:660–7.
  36. Koch J, Tuveson J, Carlson T, Schmidt J. SB-300: a new and effective therapy for HIV-associated diarrhea. Poster presented at the Seventh European Conference on Clinical Aspects and Treatment of HIV-Infection, Lisbon, Portugal, October 23–27, 1999.
  37. DuPont HL, Tidmarsh G. An open label pilot study to investigate the safety and effectiveness of orally administered Provir (SP-303) capsules in the symptomatic treatment of acute nonspecific diarrhea and traveler’s diarrhea. South San Francisco, CA: Shaman Pharmaceuticals, 1998, unpublished.
  38. Dicesare D, DuPont HL, Mathewson JJ, et al. A double-blind, randomized, placebo-controlled study of SP-303 in the symptomatic treatment of acute diarrhea among travelers to Mexico and Jamaica. Abstract presented at the Infectious Diseases Society of America, 36th Annual Meeting, Denver, CO, November 10, 1998.
  39. Ettedgui G, Schael IP, Porter S, Pennington J. A double-blind, randomized, placebo-controlled, multi-dose, phase II study to assess the safety and efficacy of SP-303 in the symptomatic treatment of acute diarrhea among adult residents of Venezuela: oral administration of 125 mg, 250 mg, or 500 mg of SP-303 given every 6 hours for 48 hours. South San Francisco, CA: Shaman Pharmaceuticals, 1998, unpublished.
  40. Holodniy M, Koch J, Mistal M, et al. A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS. Am J Gastroenterol 1999;94:3267–73.
  41. Koch J. A phase III, double-blind, randomized, placebo-controlled multi-center study of SP-303 (Provir™) in the symptomatic treatment of diarrhea in patients with acquired immunodeficiency syndrome (AIDS). Posters presented at the 13th international AIDS Conference in Durba, South Africa, July 14, 2000.
  42. Ettedgui G, Schael IP, Porter S, Pennington J. A double-blind, randomized, placebo-controlled, multi-dose, phase II study to assess the safety and efficacy of SP-303 in the symptomatic treatment of acute diarrhea among adult residents of Venezuela: oral administration of 125 mg, 250 mg, or 500 mg of SP-303 given every 6 hours for 48 hours. South San Francisco, CA: Shaman Pharmaceuticals, 1998, unpublished.
  43. Loeb H, Vandenplas Y, Wursch P, Guesry P. Tannin-rich pod for treatment of acute-onset diarrhea. J Pediatr Gastroenterol Nutr 1989;8:480–5.
  44. Eherer AH, Porter J, Fordtran JS. Effect of psyllium, calcium polycarbophil, and wheat bran on secretory diarrhea induced by phenolphthalein. Gastroenterol 1993;104:1007–12.
  45. Tyler VE. Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York: Pharmaceutical Products Press, 1994, 51–4.
  46. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1988, 101–2.
  47. Duke JA. CRC Handbook of Medicinal Plants. Boca Raton, FL: CRC Press, 1985, 209.
  48. Konig M, Scholz E, Hartmann R, et al. Ellagitannins and complex tannins from Quercus petraea bark. J Nat Prod 1994;57:1411–5.
  49. Schilcher H. Phytotherapy in Paediatrics. Stuttgart, Germany: Medpharm Scientific Publishers, 1997, 49–50.
  50. Khin-Maung-U, Myo-Khin, Nyunt-Nyunt-Wai, et al. Clinical trial of berberine in acute watery diarrhoea. Br Med J 1985;291:1601–5.
  51. Achterrath-Tuckerman U, Kunde R, et al. Pharmacological investigations with compounds of chamomile. V. Investigations on the spasmolytic effect of compounds of chamomile and Kamillosan® on isolated guinea pig ileum. Planta Med 1980;39:38–50.
  52. Su Z. Acupuncture treatment of infantile diarrhea: a report of 1050 cases. J Tradit Chin Med 1992;12:120–1.
  53. Feng WL. Acupuncture treatment for 30 cases of infantile chronic diarrhea. J Tradit Chin Med 1989;9:106–7.
  54. Lin YC. Observation of therapeutic effects of acupuncture treatment in 170 cases of infantile diarrhea. J Tradit Chin Med 1987;7:203–4.
  55. Cao Y. Personal experience on acupuncture treatment of diarrhea. J Tradit Chin Med 1990;10:163–7.
  56. Cao Y. Personal experience on acupuncture treatment of diarrhea. J Tradit Chin Med 1990;10:251–6.
  57. Lin Y, Zhou Z, Shen W, et al. Clinical and experimental studies on shallow needling technique for treating childhood diarrhea. J Tradit Chin Med 1993;13:107–14.